You are viewing: Europe Dental Soft-Tissue Regeneration Market analysis

The Europe Dental Soft-Tissue Regeneration Market was valued at $136.8 Million in 2024 and projected to reach to $195.2 Million by 2029, representing a compound annual growth rate of 7.4%. Europe's dental soft-tissue regeneration market is poised for sustained growth through 2029, driven by aging populations requiring advanced periodontal treatments and increasing investment in dental innovation.

Europe Dental Soft-Tissue Regeneration Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Dental Soft-Tissue Regeneration Market Trends and Insights

  • In Europe, the market is driven by advanced healthcare infrastructure, increasing adoption of regenerative dentistry techniques, and rising patient awareness of periodontal disease management.
  • Europe's regulatory environment and strong reimbursement frameworks support the expansion of soft-tissue regeneration solutions across dental practices and specialized clinics. The European market benefits from a mature dental care sector with high treatment acceptance rates and significant investment in dental innovation.
  • Europe's aging population and prevalence of periodontal conditions create sustained demand for soft-tissue regeneration products and procedures.
  • Between 2024 and 2029, Europe is expected to see accelerated adoption of biomaterial-based solutions and guided tissue regeneration technologies, positioning the region as a key growth market within the global dental regeneration landscape..

Key Market Statistics

  • CAGR (2024-2029) 7.4% CAGR
  • Market Size, 2024 ~USD 136.8 Million
  • Forecast, 2029 ~USD 195.2 Million
  • Geography Europe

Europe Dental Soft-Tissue Regeneration Market Overview

Market Valuation :

Europe's dental soft-tissue regeneration market reached $136.8 million in 2024, with strong growth trajectory positioning it as a key regional market within the global healthcare landscape.

Advanced Healthcare Infrastructure :

European nations benefit from sophisticated dental healthcare systems, robust regulatory frameworks, and high patient accessibility to advanced regenerative dentistry treatments, supporting market expansion.

Rising Periodontal Awareness :

Increasing patient education and clinical awareness of periodontal disease management across Europe are driving demand for soft-tissue regeneration solutions and preventive dental care.

Regenerative Dentistry Adoption :

European dental practitioners are increasingly adopting innovative regenerative techniques, supported by favorable reimbursement policies and strong clinical evidence for soft-tissue regeneration procedures.

Europe Dental Soft-Tissue Regeneration Market Dynamics

  • The region's mature healthcare infrastructure and stringent regulatory standards ensure high-quality product adoption and patient safety.
  • Germany, UK, and France lead the market, supported by strong dental professional networks and patient demand for minimally invasive regenerative solutions.
  • Continued clinical research and favorable reimbursement policies will further accelerate market penetration across European nations..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Europe's dental soft-tissue regeneration market is valued at $136.8 million in 2024 and will reach $195.2 million by 2029, growing at 7.4% CAGR.
    • Europe's advanced healthcare infrastructure and strong reimbursement policies accelerate adoption of regenerative dentistry solutions.
    • The aging European population and high prevalence of periodontal disease drive sustained demand for soft-tissue regeneration products.
    • Europe is expected to lead in biomaterial innovation and guided tissue regeneration technology adoption through 2029.

    Dental Soft-Tissue Regeneration Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment PERIODONTOLOGY (Application)
    Forecast Period 2024–2029
    Growth Rate CAGR of 7.8% from 2024 to 2029
    Largest Segment AUTOGRAFTS (Product Type)
    Market Size Base Year (Billions) ~USD 0.34 (2024)
    Revenue Forecast (Billions) ~USD 0.54 (2029)
    Segments Covered Product Type, Application, End User

    Europe Dental Soft-Tissue Regeneration Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product Type

    • Autografts
    • Collagen-Based Membranes
    • Other Products
    • Synthetic Biomaterials

    By Application

    • Implantology
    • Other Applications
    • Periodontology

    By End User

    • Academic & Research Institutes
    • Dental Hospitals
    • Dsos & Independent Clinics

    EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES10.710.81111.311.612.112.813.64.4
    DENTAL HOSPITALS41.742.844.546.549.152.356.361.36.6
    DSOS & INDEPENDENT CLINICS74.177.181.386.492.499.8109120.38.1
    TOTAL126.5130.7136.8144.2153.2164.3178195.27.4

    REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES0.950.950.960.970.991.021.071.123.3
    DENTAL HOSPITALS4.034.114.244.44.614.875.195.615.8
    DSOS & INDEPENDENT CLINICS7.157.387.728.148.649.2610.0210.987.3
    TOTAL12.1312.4412.9213.5114.2415.1516.2817.716.5

    Target Audience

    • Dental Device Manufacturers : European and global dental companies need market intelligence to develop, launch, and expand soft-tissue regeneration product portfolios in high-growth European markets.
    • Healthcare Investors & PE Firms : Investment professionals require detailed market sizing and growth forecasts to evaluate acquisition targets, fund dental innovation startups, and capitalize on Europe's regenerative dentistry expansion.
    • Dental Practitioners & Clinics : Dentists and periodontal specialists need market insights on emerging regeneration techniques, product innovations, and clinical evidence to enhance treatment offerings and patient outcomes.
    • Healthcare Consultants & Advisors : Strategy consultants supporting healthcare clients require regional market data to develop go-to-market strategies, competitive positioning, and business case analyses for European expansion.
    • Regulatory & Compliance Bodies : European regulatory agencies and healthcare policymakers need market intelligence to inform reimbursement policies, clinical guidelines, and regulatory frameworks for soft-tissue regeneration products.

    Key Companies in the Europe Dental Soft-Tissue Regeneration Market

    CompanyHQOwnershipStrongest segments
    HENRY SCHEIN, INC.United StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ENVISTAUnited StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ZIMVIE INC.United StatesPrivate CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    DENTSPLY SIRONA INC.United StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ABBVIE INC.United StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ADVANCED MEDICAL SOLUTIONS GROUP PLCUnited KingdomPublic CompanyCollagen-based Membranes,Synthetic Biomaterials,Autografts,
    TISSUE REGENIXUnited KingdomPrivate CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    MECCELLIS BIOTECHFranceCollagen-based Membranes,Synthetic Biomaterials,Autografts,

    HENRY SCHEIN, INC.

    Henry Schein, Inc. is a publicly traded American company founded in 1932 with approximately 25,000 employees. It is a leading global distributor of dental, medical, and veterinary products and services.

    ENVISTA

    Envista is a publicly traded American company founded in 2018 with approximately 12,000 employees. The company operates as a global provider of dental products, technologies, and services.

    ZIMVIE INC.

    Zimvie Inc. is a privately held American company founded in 2021 with approximately 1,770 employees. The company focuses on dental implants, bone regeneration, and related surgical solutions.

    DENTSPLY SIRONA INC.

    Dentsply Sirona Inc. is a publicly traded American company founded in 2015. The company is a leading manufacturer and distributor of dental products, technologies, and equipment.

    ABBVIE INC.

    AbbVie Inc. is a publicly traded American pharmaceutical company founded in 2012 with approximately 57,000 employees. The company develops and markets a broad range of pharmaceutical products across multiple therapeutic areas.

    ADVANCED MEDICAL SOLUTIONS GROUP PLC

    Advanced Medical Solutions Group PLC is a publicly traded British company founded in 1991 with approximately 1,800 employees. The company specializes in advanced wound care and surgical solutions.

    TISSUE REGENIX

    Tissue Regenix is a privately held British company founded in 2006 with approximately 92 employees. The company develops regenerative medicine and advanced wound care products.

    MECCELLIS BIOTECH

    Meccellis Biotech is a French company founded in 2011 that operates in the biotechnology sector. The company focuses on regenerative medicine and cellular therapy solutions.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 242.4 Million · 8.1% wtd CAGR ·
    Asia Pacific
    ~USD 70 Million · 8.9% wtd CAGR ·
    Latin America
    ~USD 21.9 Million · 6.3% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 32.41 Million
    UKUSD 25.57 Million
    FranceUSD 22.83 Million
    SpainUSD 19.05 Million
    ItalyUSD 9.31 Million
    Rest Of EuropeUSD 10.8 Million

    Country market size visualization

    Germany
    USD 32.41 Million
    UK
    USD 25.57 Million
    France
    USD 22.83 Million
    Spain
    USD 19.05 Million
    Italy
    USD 9.31 Million
    Rest Of Europe
    USD 10.8 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into Europe's $136.8M market with country-level breakdowns for Germany, UK, France, Spain, and Italy to identify high-growth opportunities and competitive landscapes.
    • Growth Forecasting : Access accurate 2029 projections ($195.2M) with 7.4% CAGR analysis to support strategic planning, investment decisions, and market entry strategies across European territories.
    • Regulatory & Reimbursement Insights : Understand Europe's favorable regulatory environment and reimbursement policies that drive adoption of soft-tissue regeneration products, enabling informed product development and commercialization strategies.
    • Competitive Intelligence : Identify leading European dental companies, emerging players, and market consolidation trends to benchmark performance and develop targeted competitive strategies within the region.
    • Clinical & Patient Trends : Leverage data on rising periodontal awareness, aging demographics, and increasing demand for minimally invasive regenerative solutions to align product portfolios with European market needs.

    Frequently asked questions

    What is the current size of Europe's dental soft-tissue regeneration market?

    Europe's dental soft-tissue regeneration market was valued at $136.8 million in 2024.

    What is the projected market size for Europe by 2029?

    Europe's dental soft-tissue regeneration market is projected to reach $195.2 million by 2029.

    What is the growth rate of Europe's dental soft-tissue regeneration market?

    Europe's market is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2029.

    What factors drive growth in Europe's dental soft-tissue regeneration market?

    Key drivers include Europe's advanced healthcare infrastructure, strong reimbursement frameworks, aging population, high prevalence of periodontal disease, and increasing adoption of regenerative dentistry techniques.

    Which technologies are gaining traction in Europe's soft-tissue regeneration market?

    Biomaterial-based solutions and guided tissue regeneration technologies are experiencing accelerated adoption across European dental practices and specialized clinics.

    RESEARCH METHODOLOGY

    This study involved four key activities to estimate the current size of the dental soft-tissue regeneration market. First, extensive secondary research was conducted to gather information about the market, as well as related markets and the overall parent market. Next, the findings, assumptions, and estimates were validated through primary research conducted with industry experts across the value chain. Both top-down and bottom-up approaches were utilized to determine the overall market size. Finally, market breakdown and data triangulation techniques were employed to estimate the sizes of various segments and subsegments.

    Secondary Research

    The secondary research process utilized a variety of sources, including directories and databases such as Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company documents, investor presentations, and SEC filings. This method was employed to gather information relevant to a comprehensive, technical, market-focused, and commercial analysis of the dental soft-tissue regeneration market. It also helped obtain crucial details about key players in the industry, market classification, and segmentation based on current trends, extending down to the most granular levels. Additionally, important developments related to market and technological perspectives were captured. A database of key industry leaders was created using the information collected through secondary research.

    Primary Research

    In the primary research process, a variety of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from important companies and organizations operating in the dental soft-tissue regeneration market. On the demand side, primary sources consisted of industry experts, purchasing and sales managers, doctors, and personnel from research organizations. This primary research aimed to validate market segmentation, identify key players, and collect insights on major industry trends and market dynamics.

    A breakdown of the primary respondents for the dental soft-tissue regeneration market is provided below:

    Dental Soft-tissue Regeneration Market

    Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.

    Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global dental soft-tissue regeneration market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global dental soft-tissue regeneration market was split into various segments and subsegments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of various dental soft-tissue regeneration manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from dental soft-tissue regenerative products (or the nearest reported business unit/product category)
    • Revenue mapping of major players to cover at least 70–75% of the global market share as of 2023
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global diagnostics market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Market Size Estimation (Bottom-up Approach & Top-down Approach)

    Dental Soft-tissue Regeneration Market

    Data Triangulation

    After arriving at the overall size of the global dental soft-tissue regeneration market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Dental soft-tissue regeneration involves restoring or reconstructing soft tissues, including the gums and connective tissues surrounding the teeth. This process seeks to facilitate the healing of tissues lost due to gum disease or trauma to enhance the health and aesthetic appearance of the gums and their functionality. These procedures can be effectively used in the treatment of gum recession, tissue defects around the implants, or any other soft-tissue defects, and eventually, to improve the smile.

    Stakeholders

    • Dental soft-tissue regenerative material manufacturing companies
    • Distributors and suppliers of dental soft-tissue regeneration products
    • Medical device companies
    • Research and consulting firms
    • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
    • Research institutes and academic centers
    • Contract research organizations (CROs)
    • Government associations
    • Venture capitalists and investors

    Report Objectives

    • To define, describe, and forecast the dental soft-tissue regeneration market based on product type, application, end user, and region
    • To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
    • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events
    • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall dental soft-tissue regeneration market
    • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To strategically profile key players in the dental soft-tissue regeneration market and comprehensively analyze their core competencies
    • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall dental soft-tissue regeneration market
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
    • To analyze the generative AI impact on the dental soft-tissue regeneration market

    Get the Full Dental Soft-Tissue Regeneration Market Report

    Full forecast, segment splits, and company analysis for all Dental Soft-Tissue Regeneration Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status